RapidArc radiotherapy for whole pelvic lymph node in cervical cancer with 6 and 15 MV: A treatment planning comparison with fixed field IMRT

Journal of Radiation Research

Volumn 54, Issue 1, 2013, Pages 166-173

  Zhai, De Yin ^a   Yin, Yong ^a   Gong, Guan Zhong ^a   Liu, Tong Hai ^a   Chen, Jin Hu ^a   Ma, Chang Sheng ^a   Lu, Jie ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

cervical cancer; dosimetry; intensity modulated radiotherapy; lymph node metastases; RapidArc

Indexed keywords

BODY FLUIDS; DISEASES; IRRADIATION; PATHOLOGY; RADIOTHERAPY;

CERVICAL CANCERS; FIELD INTENSITY; INTENSITY-MODULATED RADIOTHERAPY; LYMPH NODE METASTASIS; MONITOR UNITS; PELVIC IRRADIATION; PELVIC LYMPH NODES; RAPIDARC; TREATMENT PLANNING; X-RAY ENERGIES;

DOSIMETRY;

EID: 84872015555     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrs066     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011;61:1-22.
2. Parkin DM, Bray F, Ferlay J et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
3. Kim JH, Kim HJ, Hong S et al. Post-Hysterectomy radiotherapy in FIGO stage IBYIIB uterine cervical carcinoma. Gynecol Oncol 2005;96:407-14.
4. Rotman M, Pajak TF, Choi K et al. Prophylactic extended field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-Year treatment results of RTOG 79-20. JAMA 1995;274:387-93.
5. Ghia AJ, Neeley ES, Gaffney DK. Postoperative radiotherapy use and patterns of care analysis for node positive or parametria positive cervical cancer. Gynecol Oncol 2010;119:411-6.
6. Ahamad A, D'Souza W, Salehpour M et al. Intensity-Modulated radiation therapy after hysterectomy: Comparison with conventional treatment and sensitivity of the normal-tissuesparing effect to margin size. Int J Radiat Oncol Biol Phys 2005;62:1117-24.
7. Lukka H, Hirte H, Fyles A et al. Concurrent cisplatin based chemotherapy plus radiotherapy for cervical cancer Y a meta-analysis. Clin Oncol 2002;14:203-12.
8. Tharavichitkul E, Pinitpatcharalerd A, Lorvidhaya V et al. Impact of incomplete plan to treatment results of concurrent weekly cisplatin and radiotherapy in locally advanced cervical cancer. J Radiat Res 2011;52:9-14.
9. Lujan AE, Mundt AJ, Yamada SD et al. Intensity-Modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:516-21.
10. Mell LK, Tiryaki H, Ahn KH et al. Dosimetric comparison of bone marrow-sparing intensity-Modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:1504-10.
11. Forrest J, Presutti J, Davidson M et al. A Dosimetric Planning study comparing intensity-Modulated radiotherapy with four-field conformal pelvic radiotherapy for the definitive treatment of cervical carcinoma. Clin Oncol (R Coll Radiol) 2012;24:e63-70.
12. Brixey CJ, Roeske JC, Lujan AE et al. Impact of intensitymodulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;54:1388-96.
13. Hasselle MD, Rose BS, Kochanski JD et al. Clinical outcomes of intensity-Modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2011;80:1436-45.
14. Chen CC, Lin JC, Jan JS et al. Definitive intensity-Modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer. Gynecol Oncol 2011;122:9-13.
15. Guerrero M, Li XA, Ma L et al. Simultaneous integrated intensity-Modulated radiotherapy boost for locally advanced gynecological cancer: Radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys 2005;62:933-9.
16. Ahmed RS, Kim RY, Duan J et al. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. Int J Radiat Oncol Biol Phys 2004;60:505-12.
17. Otto K. Volumetric modulated arc therapy: IMRT in a single arc. Med Phys 2008;35:310-7.
18. Cameron C. Sweeping-window arc therapy: An implementation of rotational IMRT with automatic beam-weight calculation. Phys Med Biol 2005;50:4317-36.
19. Yoo S, Wu QJ, Lee WR et al. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes. Int J Radiat Oncol Biol Phys 2010;76: 935-42.
20. Ost P, Speleers B, De Meerleer G et al. Volumetric arc therapy and intensity-Modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: A planning comparison study. Int J Radiat Oncol Biol Phys 2011;79:920-6.
21. Cozzi L, Dinshaw KA, Shrivastava SK et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 2008;89:180-91.
22. Taylor A, Rockall AG, Reznek RH et al. Mapping pelvic lymph nodes: Guidelines for delineation in intensity-Modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:1604-12.
23. Small W, Jr, Mell LK, Anderson P et al. Consensus guidelines for delineation of clinical target volume for intensitymodulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:428-34.
24. Palma D, Vollans E, James K et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: Comparison with intensity-Modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72:996-1001.
25. Mell LK, Kochanski JD, Roeske JC et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-Modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:1356-65.
26. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
27. Gordon JJ, Weiss E, Abayomi OK et al. The effect of uterine motion and uterine margins on target and normal tissue doses in intensity modulated radiation therapy of cervical cancer. Phys Med Biol 2011;56:2887-901.
28. Beadle BM, Jhingran A, Salehpour M et al. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 2009; 73:235-41.
29. Hong JH, Tsai CS, Lai CH et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:249-57.
30. Chung HT, Xia P, Chan LW et al. Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated highrisk prostate cancer? Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys 2009;73:53-60.
31. Kry SF, Salehpour M, Followill DS et al. The calculated risk of fatal secondary malignancies from intensity-Modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005;62: 1195-203.
32. Schneider U, Lomax A, Pemler P et al. The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther Onkol 2006;182:647-52.